Teva Pharmaceutical Industries Limited (TEVA) Announces COPAXONE® Recognized As “Brand Of The Year” By Pharmaceutical Executive Magazine
5/8/2014 11:01:41 AM
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced that COPAXONE® (glatiramer acetate injection), the #1 global therapy for relapsing multiple sclerosis, has been named the 2014 “Brand of The Year” by Pharmaceutical Executive Magazine, a leading print and online publication for the biopharmaceutical industry.
Help employers find you! Check out all the jobs and post your resume.
comments powered by